During the past decade, Discovery Laboratories, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Discovery Laboratories, Inc." are "Acute Respiratory Distress Syndrome" (1 trials), "Bronchopulmonary Dysplasia" (1 trials), "Meconium Aspiration" (1 trials), "Premature Birth" (1 trials) and "Respiratory Distress Syndrome, Newborn" (1 trials). Many other conditions were trialed in "Discovery Laboratories, Inc." in a lesser frequency.

Most popular intervention types in "Discovery Laboratories, Inc." are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "A.1 Lucinactant" (1 trials), "A.2 Lucinactant" (1 trials), "A.3 Lucinactant" (1 trials), "A.4 Lucinactant" (1 trials) and "B.1 Lucinactant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Discovery Laboratories, Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Discovery Laboratories, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Discovery Laboratories, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Discovery Laboratories, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".